REFERENCES
1. Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990;66:2174-9.
2. Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009;44 Suppl 19:112-8.
3. Fukuda S, Itamoto T, Nakahara H, Kohashi T, Ohdan H, et al. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005;52:1163-7.
4. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002;6:224-32.
5. Iguchi T, Aishima S, Sanefuji K, Fujita N, Sugimachi K, et al. Both fibrous capsule formation and extracapsular penetration are powerful predictors of poor survival in human hepatocellular carcinoma: a histological assessment of 365 patients in Japan. Ann Surg Oncol 2009;16:2539-46.
6. Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987;60:810-9.
7. Hui AM, Takayama T, Sano K, Kubota K, Akahane M, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 2000;33:975-9.
8. Shimada M, Rikimaru T, Hamatsu T, Yamashita Y, Terashi T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg 2001;182:177-82.
9. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003;26:142-7.
10. Moribata K, Tamai H, Shingaki N, Mori Y, Enomoto S, et al. Assessment of malignant potential of small hypervascular hepatocellular carcinoma using B-mode ultrasonography. Hepatol Res 2011;41:233-9.
11. Sugimoto K, Moriyasu F, Kamiyama N, Metoki R, Yamada M, et al. Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography. Hepatol Res 2008;38:790-9.
12. Tanaka H, Iijima H, Higashiura A, Yoh K, Ishii A, et al. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol 2014;49:755-63.
13. Xia Y, Jiang YX, Dai Q, Xiao Y, Lv K, et al. Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation of washout time and angiogenesis. Clin Hemorheol Microcirc 2011;48:265-73.
14. Xu JF, Liu HY, Shi Y, Wei ZH, Wu Y. Evaluation of hepatocellular carcinoma by contrast-enhanced sonography: correlation with pathologic differentiation. J Ultrasound Med 2011;30:625-33.
15. Pei XQ, Liu LZ, Liu M, Zheng W, Han F, et al. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and histological grading. Br J Radiol 2012;85:e740-7.
16. Loria F, Loria G, Basile S, Crea G, Randazzo D, et al. Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy. Updates Surg 2012;64:247-55.
17. Feng Y, Qin XC, Luo Y, Li YZ, Zhou X. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation. Ultrasound Med Biol 2015;41:1553-60.
18. Hatanaka K, Chung H, Kudo M, Haji S, Minami Y, et al. Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma. Oncology 2010;78 Suppl 1:53-9.
19. Tada T, Kumada T, Toyoda H, Ito T, Sone Y, et al. Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas. Eur Radiol 2014;24:2157-66.
20. Hatanaka K, Minami Y, Kudo M, Inoue T, Chung H, et al. The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US. J Clin Ultrasound 2014;42:1-8.
21. Nuta J, Shingaki N, Ida Y, Shimizu R, Hayami S, et al. Irregular defects in hepatocellular carcinomas during the Kupffer phase of contrast-enhanced ultrasonography with perfluorobutane microbubbles: pathological features and metastatic recurrence after surgical resection. Ultrasound Med Biol 2017;43:1829-36.
22. Asayama Y, Yoshimitsu K, Nishihara Y, Irie H, Aishima S, et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. AJR Am J Roentgenol 2008;190:W28-34.
23. Sanada Y, Yoshida K, Itoh H. Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry. Oncol Rep 2007;17:1177-82.
24. Kawamura Y, Ikeda K, Hirakawa M, Yatsuji H, Sezaki H, et al. New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma. Hepatol Res 2010;40:1006-14.
25. Nishie A, Yoshimitsu K, Okamoto D, Tajima T, Asayama Y, et al. CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase. Jpn J Radiol 2013;31:89-98.
26. Nakachi K, Tamai H, Mori Y, Shingaki N, Moribata K, et al. Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography. Cancer Imaging 2014;14:7.
27. Lee JH, Lee JM, Kim SJ, Baek JH, Yun SH, et al. Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation. Br J Radiol 2012;85:e573-83.
28. Chou CT, Chen RC, Lee CW, Ko CJ, Wu HK, et al. Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging. Br J Radiol 2012;85:778-83.
29. Chou CT, Chen RC, Lin WC, Ko CJ, Chen CB, et al. Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol 2014;203:W253-9.
30. Reginelli A, Vanzulli A, Sgrazzutti C, Caschera L, Serra N, et al. Vascular microinvasion from hepatocellular carcinoma: CT findings and pathologic correlation for the best therapeutic strategies. Med Oncol 2017;34:93.
31. Wu TH, Hatano E, Yamanaka K, Seo S, Taura K, et al. A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma. Surg Today 2016;46:1275-81.
32. Hu H, Zheng Q, Huang Y, Huang XW, Lai ZC, et al. A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Sci Rep 2017;7:15375.
33. Banerjee S, Wang DS, Kim HJ, Sirlin CB, Chan MG, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology 2015;62:792-800.
34. Zhao H, Hua Y, Dai T, He J, Tang M, et al. Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma. Eur J Radiol 2017;88:32-40.
35. Muramatsu Y, Nawano S, Takayasu K, Moriyama N, Yamada T, et al. Early hepatocellular carcinoma: MR imaging. Radiology 1991;181:209-13.
36. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992;183:819-25.
37. Ebara M, Fukuda H, Kojima Y, Morimoto N, Yoshikawa M, et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999;210:81-8.
38. Enomoto S, Tamai H, Shingaki N, Mori Y, Moribata K, et al. Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis. Hepatol Int 2011;5:730-7.
39. Min JH, Kim YK, Lim S, Jeong WK, Choi D, et al. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol 2015;84:1036-43.
40. Heo SH, Jeong YY, Shin SS, Kim JW, Lim HS, et al. Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor. Korean J Radiol 2010;11:295-303.
41. Nishie A, Tajima T, Asayama Y, Ishigami K, Kakihara D, et al. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol 2011;80:e29-33.
42. Nakanishi M, Chuma M, Hige S, Omatsu T, Yokoo H, et al. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol 2012;19:1302-9.
43. Tang Y, Wang H, Ma L, Zhang X, Yu G, et al. Diffusion-weighted imaging of hepatocellular carcinomas: a retrospective analysis of correlation between apparent diffusion coefficients and histological grade. Abdom Radiol (NY) 2016;41:1539-45.
44. Li X, Zhang K, Shi Y, Wang F, Meng X. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade. J Magn Reson Imaging 2016;44:1442-7.
45. Xu P, Zeng M, Liu K, Shan Y, Xu C, et al. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? J Gastroenterol Hepatol 2014;29:330-6.
46. Suh YJ, Kim MJ, Choi JY, Park MS, Kim KW. Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging. Liver Transpl 2012;18:1171-8.
47. Okamura S, Sumie S, Tonan T, Nakano M, Satani M, et al. Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma. Dig Liver Dis 2016;48:945-52.
48. Chen J, Wu M, Liu R, Li S, Gao R, et al. Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis. PLoS One 2015;10:e0117661.
49. Park IK, Yu JS, Cho ES, Kim JH, Chung JJ. Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging. PLoS One 2018;13:e0197070.
50. Moriya T, Saito K, Tajima Y, Harada TL, Araki Y, et al. 3D analysis of apparent diffusion coefficient histograms in hepatocellular carcinoma: correlation with histological grade. Cancer Imaging 2017;17:1.
51. Ogihara Y, Kitazume Y, Iwasa Y, Taura S, Himeno Y, et al. Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study. Br J Radiol 2018;91:20170728.
52. Iwasa Y, Kitazume Y, Tateishi U, Saida Y, Ban D, et al. Hepatocellular carcinoma histological grade prediction: a quantitative comparison of diffusion-weighted, T2-weighted, and hepatobiliary-phase magnetic resonance imaging. J Comput Assist Tomogr 2016;40:463-70.
53. Mori Y, Tamai H, Shingaki N, Moribata K, Deguchi H, et al. Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation. Hepatol Res 2015;45:75-87.
54. Zhao W, Liu W, Liu H, Yi X, Hou J, et al. Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2018;13:e0197488.
55. Wang WT, Yang L, Yang ZX, Hu XX, Ding Y, et al. Assessment of microvascular invasion of hepatocellular carcinoma with diffusion kurtosis imaging. Radiology 2018;286:571-80.
56. Chang WC, Chen RC, Chou CT, Lin CY, Yu CY, et al. Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images. Abdom Imaging 2014;39:1202-12.
57. Kim KA, Kim MJ, Jeon HM, Kim KS, Choi JS, et al. Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 2012;35:629-34.
58. Lee S, Kim SH, Lee JE, Sinn DH, Park CK. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 2017;67:526-34.
59. Hu HT, Shen SL, Wang Z, Shan QY, Huang XW, et al. Peritumoral tissue on preoperative imaging reveals microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis. Abdom Radiol (NY) 2018;43:3324-30.
60. Tada T, Kumada T, Toyoda H, Ito T, Sone Y, et al. Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography. J Gastroenterol 2015;50:85-94.
61. Chen C, Zhao H, Fu X, Huang L, Tang M, et al. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma. Oncotarget 2017;8:29741-50.
62. Kobayashi T, Aikata H, Hatooka M, Morio K, Morio R, et al. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma. Eur Radiol 2015;25:3272-81.
63. Iwamoto T, Imai Y, Kogita S, Igura T, Sawai Y, et al. Comparison of contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI for the diagnosis of macroscopic type of hepatocellular carcinoma. Dig Dis 2016;34:679-86.
64. Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 2008;249:624-30.
65. Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, et al. Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res 2014;44:846-53.
66. Masuda T, Beppu T, Okabe H, Nitta H, Imai K, et al. Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasion. Hepatol Res 2016;46:985-91.
67. Kobayashi T, Aikata H, Honda F, Nakano N, Nakamura Y, et al. Preoperative fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for prediction of microvascular invasion in small hepatocellular carcinoma. J Comput Assist Tomogr 2016;40:524-30.
68. Zhang X, Li J, Shen F, Lau WY. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 2018;33:347-54.
